Article
CAR-T-associated cardiac toxicity 'limited and reversible' in younger patients with ALL
Rating:
0.0
Views:
62
Likes:
1
Library:
1
Cardiovascular toxicity associated with chimeric antigen receptor T-cell therapy is both limited and reversible among high-risk children and young adults with acute lymphoblastic leukemia, according to results of a phase 1 clinical trial.The findings — published in Journal for ImmunoTherapy of Cancer — showed cardiac toxicity related to cytokine release syndrome (CRS) after therapy
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value